Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Raju Sunagar, Sudeep Kumar, Brian J Franz & Edmund J Gosselin. (2016) Tularemia vaccine development: paralysis or progress?. Vaccine: Development and Therapy 6, pages 9-23.
Read now
Read now
Pentti Koskela & Elja Herva. (1982) Immunity against Francisella Tularensis in Northern Finland. Scandinavian Journal of Infectious Diseases 14:3, pages 195-199.
Read now
Read now
Articles from other publishers (21)
Klara Kubelkova, Tomas Hudcovic, Hana Kozakova, Jaroslav Pejchal & Ales Macela. (2021) Early infection-induced natural antibody response. Scientific Reports 11:1.
Crossref
Crossref
Heather F. Sateia, Michael T. Melia & Joseph CofrancescoJrJr. (2017) Tularemia presenting as suspected necrotic arachnidism. Clinical Case Reports 5:4, pages 497-500.
Crossref
Crossref
K. Kubelkova & A. Macela. (2015) Putting the Jigsaw Together - A Brief Insight Into the Tularemia. Open Life Sciences 10:1.
Crossref
Crossref
Om Prakash Singh & Shyam Sundar. (2014) Whole blood assay and visceral leishmaniasis: Challenges and promises. Immunobiology 219:4, pages 323-328.
Crossref
Crossref
Qingmei Jia, Richard Bowen, Jacob Sahakian, Barbara Jane Dillon & Marcus A. Horwitz. (2013)
A Heterologous Prime-Boost Vaccination Strategy Comprising the Francisella tularensis Live Vaccine Strain
capB
Mutant and Recombinant Attenuated Listeria monocytogenes Expressing F. tularensis IglC Induces Potent Protective Immunity in Mice against Virulent F. tularensis Aerosol Challenge
. Infection and Immunity 81:5, pages 1550-1561.
Crossref
Crossref
H.M. El Sahly, R.L. Atmar, S.M. Patel, J.M. Wells, T. Cate, M. Ho, K. Guo, M.F. Pasetti, D.E. Lewis, M.B. Sztein & W.A. Keitel. (2009) Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humans. Vaccine 27:36, pages 4905-4911.
Crossref
Crossref
Lisa Hodges & Robert L. Penn. 2009. Bioterrorism and Infectious Agents: A New Dilemma for the 21st Century. Bioterrorism and Infectious Agents: A New Dilemma for the 21st Century
71
98
.
Lise E. Nigrovic & Sarah L. Wingerter. (2008) Tularemia. Infectious Disease Clinics of North America 22:3, pages 489-504.
Crossref
Crossref
Henrik Eliasson, Per Olcén, Anders Sjöstedt, Margareta Jurstrand, Erik Bäck & Sören Andersson. (2008) Kinetics of the Immune Response Associated with Tularemia: Comparison of an Enzyme-Linked Immunosorbent Assay, a Tube Agglutination Test, and a Novel Whole-Blood Lymphocyte Stimulation Test. Clinical and Vaccine Immunology 15:8, pages 1238-1243.
Crossref
Crossref
W. D. Splettstoesser, H. Tomaso, S. Al Dahouk, H. Neubauer & P. Schuff-Werner. (2005) Diagnostic Procedures in Tularaemia with Special Focus on Molecular and Immunological Techniques. Journal of Veterinary Medicine Series B 52:6, pages 249-261.
Crossref
Crossref
Lisa Hodges & Robert L. Penn. 2005. Bioterrorism and Infectious Agents: A New Dilemma for the 21st Century. Bioterrorism and Infectious Agents: A New Dilemma for the 21st Century
71
98
.
Siske S. StruikFakhreldin M. OmerKaterina Artavanis-TsakonasEleanor M. Riley. (2004) Uninfected erythrocytes inhibit Plasmodium falciparum–induced cellular immune responses in whole-blood assays. Blood 103:8, pages 3084-3092.
Crossref
Crossref
R.E. Weir, A.R. Morgan, W.J. Britton, C.R. Butlin & H.M. Dockrell. (1994) Development of a whole blood assay to measure T cell responses to leprosy: a new tool for immuno-epidemiological field studies of leprosy immunity. Journal of Immunological Methods 176:1, pages 93-101.
Crossref
Crossref
H M SurcelH SyrjäläM LeinonenP SaikkuE Herva. (1993) Cell-mediated immunity to Chlamydia pneumoniae measured as lymphocyte blast transformation in vitro. Infection and Immunity 61:5, pages 2196-2199.
Crossref
Crossref
H M Surcel. (1990) Diversity of Francisella tularensis antigens recognized by human T lymphocytes. Infection and Immunity 58:8, pages 2664-2668.
Crossref
Crossref
H.-M. Surcel, M. Sarvas, I.M. Helander & E. Herva. (1989) Membrane proteins of Francisella tularensis LVS differ in ability to induce proliferation of lymphocytes from tularemia-vaccinated individuals. Microbial Pathogenesis 7:6, pages 411-419.
Crossref
Crossref
R Karttunen, G Andersson, H P Ekre, K Juutinen, H M Surcel, H Syrjälä & E Herva. (1987) Interleukin 2 and gamma interferon production, interleukin 2 receptor expression, and DNA synthesis induced by tularemia antigen in vitro after natural infection or vaccination. Journal of Clinical Microbiology 25:6, pages 1074-1078.
Crossref
Crossref
P Koskela & A Salminen. (1985) Humoral immunity against Francisella tularensis after natural infection. Journal of Clinical Microbiology 22:6, pages 973-979.
Crossref
Crossref
Robert E. HarrellJr.Jr. & Gary R. Whitaker. (1985) Tularemia: Emergency department presentation of an infrequently recognized disease. The American Journal of Emergency Medicine 3:5, pages 415-418.
Crossref
Crossref
R Karttunen, J Ilonen & E Herva. (1985) Interleukin 2 production in whole blood culture: a rapid test of immunity to Francisella tularensis. Journal of Clinical Microbiology 22:2, pages 318-319.
Crossref
Crossref
P Koskela & E Herva. (1982) Cell-mediated and humoral immunity induced by a live Francisella tularensis vaccine. Infection and Immunity 36:3, pages 983-989.
Crossref
Crossref